Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9505 - 9512 of 12011 results
The EEOC Provides Welcome Guidance on Employment-Based Wellness Plans
April 22, 2015| Blog| Viewpoint
California Non-Compete Update: No Re-Hire Provisions May Be in Jeopardy, Especially for Large Employers
April 22, 2015| Blog| Viewpoint
PROPEL: Helping to build a smarter, interconnected, resource-efficient world
April 22, 2015| Blog| Viewpoint
FTC Flushes McWane in a Big Eleventh Circuit Exclusive Dealing Win
April 22, 2015| Alert| Viewpoint
FCC Chairman Tom Wheeler Speaks about Cybersecurity at RSA Conference
April 22, 2015| Blog| Viewpoint
Helping U.S. Patent Applicants Get Speedy Examination
April 22, 2015| Blog| Viewpoint
5 Takeaways from the HHS OIG's Guidance for Health Care Governing Boards
April 22, 2015| Blog| Viewpoint
How New York’s Emergency Medical Services and Surprise Bills Law Impacts Providers and Plans
April 21, 2015| Advisory| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|